Synagis is administered to children under the age of two that are at high risk for severe lower respiratory tract illness caused by the Respiratory Syncytial Virus (RSV).
South Dakota medical assistance recipients receiving this medication must be under the care/consultation of a neonatologist, pediatric pulmonologist, or pediatric cardiologist. These specialists must co-sign the authorization form.
This approval process is based on the American Academy of Pediatric (AAP) guidelines and is required prior to reimbursement.
Instructions:
Synagis and Respigam are covered by the South Dakota Medical Assistance Program when a child meets all of the following criteria:
Billing Instructions: Physicians Office
Form: CMS 1500
Procedure Code: 90378
Rate of Payment: Changes have been made regarding the rate of payment and billing units of Synagis. Synagis is now reimbursed at the rate specified on the Physician Services fee schedule. Amounts must be billed in 50 milligram units.
Form: UB92
Revenue Code: 636 with Procedure Code 90378
Rate of Payment: Hospital’s Outpatient Rate
Prior Authorization Number: Enter this number in Block 63A. The same authorization number may be used for the entire series.
Procedure Code: 99506